TERRI TOPE: Open Payments
NPI 1427090919 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$584 in 22 payments from 9 companies in 2025. Trend: 2023 $310 · 2024 $364 · 2025 $584
Food & beverage: $500Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $252 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $87 |
| ABBVIE INC. | 3 | $79 |
| Novartis Pharmaceuticals Corporation | 2 | $50 |
| Madrigal Pharmaceuticals | 1 | $30 |
| Ipsen Biopharmaceuticals, Inc | 1 | $27 |
| Aimmune Therapeutics, Inc. | 1 | $26 |
| Celltrion USA Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
Products named: TREMFYA, ENTYVIO, Fabhalta, REZDIFFRA, MAVYRET, RINVOQ, IQIRVO, ZENPEP.
Industry payments across AK — which companies pay providers there.
